Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.
The prospective analysis suggests that the approach could help clinicians identify patients at risk of a stroke who could benefit from anticoagulant treatment.
Researchers also combined the 121 SNPs they found with pharmacy data to develop a risk score to predict when patients would start lipid-lowering treatments.
During a two-year pilot, the Genomic Ascertainment Cohort will collect 10,000 genotypes and make patients available for follow-up exams to confirm predictions.
By genotyping nearly 200 Mycobacterium bovis isolates, investigators saw signs of introductions of the pathogen, coupled with a long history in the region.
Mars Petcare's genetic testing unit and Genoscoper had been collaborating since 2015 to discover new genetic health markers for companion animals.
The model aims to uncover stroke patients at high, medium, or low risk of cerebral amyloid angiopathy, which is linked to additional strokes or dementia.
In an observational study, a Tulane University-led team found that people at genetic risk of obesity who started to eat a healthy diet lost more weight than those not at risk.
Milwaukee, Wis.-based TAI Diagnostics is developing a PCR-based assay for cell-free DNA as a way to monitor the health of transplanted organs.
Organizers will not only collect genetic data on participants, but report back genetic risks via the country's national health information system.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.